digital twins

Unlearn leverages digital twin models to simulate how participants may respond to treatments, according to CEO Steve Herne. This approach streamlines clinical trials by enhancing data precision and improving the quality of outcomes.

Trace will use Unlearn's digital twin generator for ALS to create digital twins of clinical trial participants to advance ALS research. 

The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.

With the creation of digital twins in studies, Unlearn generates an intelligent control arm that can reduce the sample size and decrease the number of participants given the placebo.